Inauguration Ceremony
Inauguration Ceremony of the New Filling Line at the Takeda Manufacturing Site in Neuchâtel
The new facility has been constructed using the most advanced technologies in the industry and with a higher level of automation including a strong focus on data and digital technologies. Our strategic investments of CHF 200 million will significantly enhance production capacity to better meet unmet medical needs and better serve patients with rare diseases.
We are looking forward to celebrating this important milestone with you, alongside Federal Councilor Guy Parmelin, representatives from the canton and city of Neuchâtel as well as members of our Executive Team.
26 November 2025
Location
How to Get to the Takeda Neuchâtel Site
By Car:
The site is easy to reach by car, and on-site parking spaces are available for guests. You can find the detailed parking overview here.
By Public Transport:
From Neuchâtel train station, take bus 109 or 423 (approx. 10 minutes). Exit at the stop “Neuchâtel, Pierre-à-Bot”, located just a short walk from the Takeda facility.
Schedule
16:45 - 17:00
Arrival & Registration
17:00 - 17:30
Transfer to the new manufacturing site
17:30 - 17:35
Welcome words by Takeda representatives
Sebastien Bourgeois
17:35 - 17:45
Key Note by Takeda representatives
Thomas Wozniewski
17:45 - 17:55
Key Note Government representatives
Florence Nater
17:55 - 18:05
Key Note Government representatives
H. E. Toshiro Iijima
18:05 - 18:15
Key Note Government representatives
Guy Parmelin
18:15 - 18:20
Closing note
Traditional Daruma Doll on Stage
Sebastien Bourgeois
18:20 - 18:30
Official ribbon cut ceremony
18:30 - 20:00
Reception
Speakers
Guy Parmelin
Federal Councilor, EAER
Thomas Wozniewski
Takeda, Global Manufacturing and Supply Officer
Sebastien Bourgeois
Takeda, Site Head Neuchâtel
H. E. Toshiro Iijima
Ambassador-designate of Japan
Florence Nater
State Councilor, Head of the Department of Economy and Social Cohesion (DECS)
Press
Press Release
Press Release download
Takeda aims to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet.
Entering the Swiss market in 1986, Takeda is the fifth largest biotechnology company in Switzerland today. With 1,900 employees, of which approximately 700 are working at our production site in Neuchâtel, we are serving patients in over 80 countries. At the facility, we manufacture life-transforming treatments for patients with rare diseases. The site will celebrate its 30th anniversary in 2026. For more information, visit www.takeda.com.
Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved